Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?

@article{Boytchev2021WhyDA,
  title={Why did a German newspaper insist the Oxford AstraZeneca vaccine was inefficacious for older people—without evidence?},
  author={Hristio Boytchev},
  journal={BMJ},
  year={2021},
  volume={372}
}
Reporting information from single anonymous sources that turns out to be false could erode public confidence in the vaccines that are crucial to controlling the covid-19 pandemic. Hristio Boytchev reports 

Comparative Study of the Information about the COVID-19 Pandemic and COVID-19 Vaccines on the Covers of United Kingdom, France, Spain and United States’ Main Newspapers

This study compares the information coverage of the vaccine against the information of the COVID-19 pandemic in eight newspapers (two per country) from the United Kingdom, France, Spain and the

Factors Affecting Hesitancy to mRNA and Viral Vector COVID-19 Vaccines among College Students in Italy

Taking into consideration the factors involved in vaccine hesitancy/resistance in college students could represent a key public health strategy to increase vaccine coverage and reduce viral spreading.

Changes in Attitudes and Beliefs Concerning Vaccination and Influenza Vaccines between the First and Second COVID-19 Pandemic Waves: A Longitudinal Study

Previous influenza vaccinations, receipt of a COVID-19 vaccine, positive attitudes towards (influenza) vaccination, male sex, and older age were the main correlates of willingness to receive the 2021/22 influenza vaccine.

Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers

Females and the younger age group were associated with an increased risk of side effects either after mRNA-based or viral vector-based vaccines, and the gender- and age-based differences warrant further rigorous investigation and standardized methodology.

The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland

The study shows the level of trust in COVID-19 vaccines can vary much across the producers while the mRNA vaccines are received with a high level of acceptance and emphasizes the need for effective and continuous science communication when fighting the pandemic.

Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases

  • A. KronbichlerH. Anders A. Bruchfeld
  • Biology, Medicine
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2021
Abstract Coronavirus Disease 19 (COVID-19) vaccine platforms are becoming available and are the most promising strategy to curb the spread of SARS-CoV-2 infections. However, numerous uncertainties